Expert Opinion on Drug Safety
Volume 21, 2022 - Issue 10
Open access
1,847
Views
0
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation
Safety evaluation of perampanel as monotherapy or first adjunctive therapy in patients with epilepsy
James WhelessUniversity of Tennessee Health Science Center, Le Bonheur Children’s Hospital, Memphis, TN, USACorrespondence[email protected]
https://orcid.org/0000-0002-4735-3431View further author information
Nitish ChourasiaUniversity of Tennessee Health Science Center, Le Bonheur Children’s Hospital, Memphis, TN, USA
https://orcid.org/0000-0002-9204-4849View further author information
Pages 1239-1247
|
Received 06 Apr 2022, Accepted 07 Oct 2022, Published online: 30 Oct 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.